Evidence map›Paper›PMID 41438622›Full record

ArticleJournal of tropical medicine2025

Quantum-Mechanically Refined, Dynamics-Coupled, and AI-Augmented Elucidation of Epigenetic Inhibition: An In Silico Paradigm Targeting HDAC8 of

Mohd Imran, Talha Jawaid, Hayaa M Alhuthali, Amani A Alrehaili, Abdullah R Alzahrani, Zia Ur Rehman, Elliot Mbunge, Tafadzwa Dzinamarira

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of tropical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mohd ImranCenter for Health Research, Northern Border University, Arar, 73213, Saudi Arabia, nbu.edu.sa.ORCID https://orcid.org/0000-0002-6064-1040
Talha JawaidDepartment of Pharmacology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia, imamu.edu.sa.ORCID https://orcid.org/0000-0003-2224-5298
Hayaa M AlhuthaliDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif, 21944, Saudi Arabia, tu.edu.sa.ORCID https://orcid.org/0000-0001-5999-081X
Amani A AlrehailiDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif, 21944, Saudi Arabia, tu.edu.sa.ORCID https://orcid.org/0000-0002-5691-9118
Abdullah R AlzahraniDepartment of Pharmacology and Toxicology, Faculty of Medicine, Umm Al-Qura University, P.O. Box 13578 Al-Abidiyah, Makkah, 21955, Saudi Arabia, uqu.edu.sa.ORCID https://orcid.org/0000-0001-7782-0574
Zia Ur RehmanHealth Research Centre, Jazan University, P.O. Box 114, Jazan, 45142, Saudi Arabia, jazanu.edu.sa.ORCID https://orcid.org/0000-0002-6540-7966
Elliot MbungeDepartment of Applied Information Systems, University of Johannesburg, Johannesburg, South Africa, uj.ac.za.ORCID https://orcid.org/0000-0003-4504-6697
Tafadzwa DzinamariraSchool of Health Systems and Public Health, University of Pretoria, Pretoria, South Africa, up.ac.za.ORCID https://orcid.org/0000-0002-9929-5739

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing burden of schistosomiasis, compounded by the restriction imposed by monotherapeutic regimens, highlights the pressing need for new molecules that target specific molecular pathways.

Indexed as

DFTHDAC8machine learningSchistosoma mansonischistosomiasis

Identifiers

PMID41438622
PMCPMC12721395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.